Medical Condition News

RSS

AAOS releases clinical practice guideline to treat rotator cuff tears

The American Academy of Orthopaedic Surgeons Board of Directors approved and released a clinical practice guideline for treating rotator cuff tears.

4 Mar 2011

Executioner enzyme may short circuit second form of cell death

An enzyme viewed as an executioner, because it can push cells to commit suicide, may actually short circuit a second form of cell death, researchers at Emory University School of Medicine have discovered.

4 Mar 2011

Springtime may cause or worsen dry eye condition

Springtime may be just what the doctor orders for individuals suffering from dry eye condition, a disorder resulting from insufficient tear production or altered tear film composition. According to a study published in Investigative Ophthalmology & Visual Science, a temperature less than 30 degrees Celsius on the eye and eyelid could be the cause for the onset or worsening of the disorder.

4 Mar 2011

$Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors$

Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors

The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors.

4 Mar 2011

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

Talecris granted EU orphan drug designation for Plasmin (human) to treat acute peripheral arterial occlusion

Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO). Talecris is currently investigating Plasmin in a phase II clinical trial designed to assess its ability to treat aPAO, a condition in which arterial blood flow to the extremities, usually the legs, is blocked by a clot.

4 Mar 2011

U.S. Representatives, Gene Green introduce bipartisan bill to ensure Medicare reimbursement

U.S. Representatives Ed Whitfield and Gene Green today introduced H.R. 905.

4 Mar 2011

Low physical activity increases kidney transplant patients' likelihood of dying early

Low physical activity increases kidney transplant patients' likelihood of dying early, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest that patients need to exercise to fend off an early death.

4 Mar 2011

Exercise can reduce cannabis use in persons who don't want to stop

Vanderbilt researchers are studying heavy users of marijuana to help understand what exercise does for the brain, contributing to a field of research that uses exercise as a modality for prevention and treatment.

4 Mar 2011

Efficiency of brain function depends on family's genetic makeup

How well our brain functions is largely based on our family's genetic makeup, according to a University of Melbourne led study.

4 Mar 2011

Hemispherx, Chronix jointly file US patent application for CFS blood test

Chronix Biomedical announced today that it filed a provisional United States patent application jointly with Hemispherx Biopharma, Inc. on a blood test for Chronic Fatigue Syndrome.

4 Mar 2011

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

Allos Therapeutics, Inc. today announced that the Company has reached agreement with the U.S. Food and Drug Administration (FDA) under its Special Protocol Assessment (SPA) process for the design of the Company's Phase 3 clinical trial of FOLOTYN® (pralatrexate injection) in patients with previously undiagnosed peripheral T-cell lymphoma (PTCL).

4 Mar 2011

AHRQ: More than 59 million Americans diagnosed with high blood pressure in 2008

More than 59 million Americans age 18 and older were diagnosed with high blood pressure in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

4 Mar 2011

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Palatin Technologies, Inc. today announced that the U.S. Food and Drug Administration has cleared Palatin's request to begin a Phase 2A proof-of-concept human trial under an Investigational New Drug application using a subcutaneously administered formulation of PL-3994, an NPR-A agonist compound, in development for treatment of acute exacerbations of asthma.

4 Mar 2011

VDF urges Americans to learn about risks of DVT to help prevent death

Each year between 100,000-180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges Americans, especially women, to learn about the risks of venous blood clots to help prevent these deaths.

3 Mar 2011

Medical Condition News

AAOS releases clinical practice guideline to treat rotator cuff tears

Executioner enzyme may short circuit second form of cell death

Springtime may cause or worsen dry eye condition

Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

Talecris granted EU orphan drug designation for Plasmin (human) to treat acute peripheral arterial occlusion

U.S. Representatives, Gene Green introduce bipartisan bill to ensure Medicare reimbursement

Low physical activity increases kidney transplant patients' likelihood of dying early

Exercise can reduce cannabis use in persons who don't want to stop

Efficiency of brain function depends on family's genetic makeup

Hemispherx, Chronix jointly file US patent application for CFS blood test

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

AHRQ: More than 59 million Americans diagnosed with high blood pressure in 2008

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

VDF urges Americans to learn about risks of DVT to help prevent death

Neuropathologist receives AAN Potamkin Prize for Alzheimer's disease research

PDI introduces new division for clinical educators to optimize patient care and outcomes

Scientist receives $4 million Australia fellowship to continue cancer origin research

CAS is an economically attractive alternative to endarterectomy for stroke patients

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Latest News